SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
UNSW Sydney · The George Institute for Global Health · +11 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
867
total citations
- FWCI
- 76.26
- Percentile
- 100%
- References
- 46
Citations per year
Authors
13- BLBrendon L. Neuen
UNSW Sydney, The George Institute for Global Health
- TKT. Kue Young
The George Institute for Global Health, UNSW Sydney
- HJHiddo J.L. Heerspink
University of Groningen, University Medical Center Groningen, The George Institute for Global Health, UNSW Sydney
- BNBruce Neal
Imperial College London, The George Institute for Global Health, The University of Sydney, UNSW Sydney
- VPVlado Perkovic
UNSW Sydney, The George Institute for Global Health
Topics & keywords
Topics
Keywords
- Medicine
- Empagliflozin
- Albuminuria
- Meta-analysis
- Kidney disease
- Dialysis
- Kidney transplantation
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BIBoehringer Ingelheim
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- BABrigham and Women's Hospital
- GSGilead Sciences
- AAblynx
- ZMZOLL Medical Corporation
- MMyoKardia
- VLVerily Life Sciences
- UOUniversity of Oxford
- UOUniversity of New South Wales
- NNNovo Nordisk
- APAstellas Pharma
- SServier
- ATAkebia Therapeutics
- MRMedical Research Council
- NHNational Health and Medical Research Council
- RRelypsa
- JPJanssen Pharmaceuticals